This content is from: Patents

Drug-access backers may push know-how sharing in WHO deal

Advocates say the new pandemic preparedness treaty will be a good opportunity to promote a refocus of the debate away from forced licensing

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial